{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:12:33Z","timestamp":1785831153897,"version":"3.56.0"},"reference-count":71,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNP"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1176\/jnp.10.1.10","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T23:12:05Z","timestamp":1418857925000},"page":"10-19","source":"Crossref","is-referenced-by-count":84,"title":["Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease"],"prefix":"10.1176","volume":"10","author":[{"given":"Glenda M.","family":"MacQueen","sequence":"first","affiliation":[{"name":"Received August 13, 1996; revised January 10, 1997; accepted January 13, 1997. From the Departments of Psychiatry and Medicine, Division of Neurology, and Biomedical Sciences, Division of Neuroscience, McMaster University Medical Centre, Hamilton, Ontario, Canada. Address correspondence to Dr. MacQueen, Department of Psychiatry, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia I.","family":"Rosebush","sequence":"additional","affiliation":[{"name":"Received August 13, 1996; revised January 10, 1997; accepted January 13, 1997. From the Departments of Psychiatry and Medicine, Division of Neurology, and Biomedical Sciences, Division of Neuroscience, McMaster University Medical Centre, Hamilton, Ontario, Canada. Address correspondence to Dr. MacQueen, Department of Psychiatry, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Mazurek","sequence":"additional","affiliation":[{"name":"Received August 13, 1996; revised January 10, 1997; accepted January 13, 1997. From the Departments of Psychiatry and Medicine, Division of Neurology, and Biomedical Sciences, Division of Neuroscience, McMaster University Medical Centre, Hamilton, Ontario, Canada. Address correspondence to Dr. MacQueen, Department of Psychiatry, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R5P9040351","doi-asserted-by":"crossref","unstructured":"Johnson WG: The clinical spectrum of hexosaminidase deficiency diseases. Neurology 1981; 31:1453\u20131456","DOI":"10.1212\/WNL.31.11.1453"},{"key":"R5P9040353","unstructured":"Tay W: Symmetrical changes in the region of the yellow spot in each eye of an infant. Transactions of the Ophthalmological Societies of the United Kingdom 1881; 1:55"},{"key":"R5P9040354","doi-asserted-by":"crossref","unstructured":"Sachs B: On arrested cerebral development with special reference to its cortical development. J Nerv Ment Dis 1887; 14:541\u2013553","DOI":"10.1097\/00005053-188709000-00001"},{"key":"R5P9040355","doi-asserted-by":"crossref","unstructured":"Suzuki K, Suzuki K, Chen GC: Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis. J Neuropathol Exp Neurol 1968; 27:15\u201338","DOI":"10.1097\/00005072-196801000-00002"},{"key":"R5P9040356","doi-asserted-by":"crossref","unstructured":"Suzuki K, Suzuki K, Rapin I, et al: Juvenile GM2 gangliosidosis: clinical variant of Tay-Sachs disease or a new disease? Neurology 1970; 20:190\u2013204","DOI":"10.1212\/WNL.20.2.190"},{"key":"R5P9040357","doi-asserted-by":"crossref","unstructured":"Meek D, Wolfe LS, Andermann F, et al: Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. Ann Neurol 1984; 15:348\u2013352","DOI":"10.1002\/ana.410150408"},{"key":"R5P9040358","unstructured":"Navon R, Padeh B, Adam A: Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet 1973; 25:287\u2013292"},{"key":"R5P9040359","doi-asserted-by":"crossref","unstructured":"Rapin I, Suzuki K, Suzuki K, et al: Adult (chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol 1976; 33:120\u2013130","DOI":"10.1001\/archneur.1976.00500020048008"},{"key":"R5P90403510","doi-asserted-by":"crossref","unstructured":"Navon R: Molecular and clinical heterogeneity of adult GM2 gangliosidosis. Dev Neurosci 1991; 13:295\u2013298","DOI":"10.1159\/000112200"},{"key":"R5P90403511","doi-asserted-by":"crossref","unstructured":"Navon R, Proia RL: The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 1989; 243:1471\u20131474","DOI":"10.1126\/science.2522679"},{"key":"R5P90403512","doi-asserted-by":"crossref","unstructured":"Ohna K, Suzuki K: A splicing defect due to an exon-intron junction mutation results in abnormal beta-hexosaminidase alpha-chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun 1988; 153:463\u2013469","DOI":"10.1016\/S0006-291X(88)81247-6"},{"key":"R5P90403513","unstructured":"Paw BH, Kaback MM, Lim J, et al: Frequency of three HEX A mutation alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program. Am J Hum Genet 1990; 47:697\u2013704"},{"key":"R5P90403514","doi-asserted-by":"crossref","unstructured":"Suzuki K, Vanier MT: Biochemical and molecular aspects of late-onset GM2 gangliosidosis: B1 variant as a prototype. Dev Neurosci 1991; 13:288\u2013294","DOI":"10.1159\/000112175"},{"key":"R5P90403515","doi-asserted-by":"crossref","unstructured":"Ledeen R: Gangliosides of the neuron. Trends Neurosci 1985; 8:169\u2013174","DOI":"10.1016\/0166-2236(85)90064-5"},{"key":"R5P90403516","doi-asserted-by":"crossref","unstructured":"Ando S: Gangliosides of the nervous system. Neurochem Int 1983; 5:507\u2013536","DOI":"10.1016\/0197-0186(83)90043-8"},{"key":"R5P90403517","doi-asserted-by":"crossref","unstructured":"Nobile-Orazio E, Carpo M, Scarlato G: Gangliosides: their role in clinical neurology. Drugs 1994; 47:576\u2013585","DOI":"10.2165\/00003495-199447040-00002"},{"key":"R5P90403518","doi-asserted-by":"crossref","unstructured":"Leinekugel P, Michel S, Conzelmann E, et al: Qualitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting liposomal storage disease. Hum Genet 1992; 88:513\u2013523","DOI":"10.1007\/BF00219337"},{"key":"R5P90403519","doi-asserted-by":"crossref","unstructured":"Conzelmann E, Sandhoff K: Biochemical basis of late-onset neurolipidoses. Dev Neurosci 1991; 13:197\u2013204","DOI":"10.1159\/000112160"},{"key":"R5P90403520","doi-asserted-by":"crossref","unstructured":"Purpura DP, Suzuki K: Distortion of neuronal geometry and formation of aberrant synopsis in neuronal storage disease. Brain Res 1976; 116:1\u201321","DOI":"10.1016\/0006-8993(76)90245-6"},{"key":"R5P90403521","doi-asserted-by":"crossref","unstructured":"Purpura DP, Baker H: Meganeurites and other aberrant processes of neurons in feline GM1 gangliosis: a golgi study. Brain Res 1977; 143:13\u201326","DOI":"10.1016\/0006-8993(78)90749-7"},{"key":"R5P90403523","doi-asserted-by":"crossref","unstructured":"Walkley SU: Pathobiology of neuronal storage disease. Int Rev Neurobiol 1988; 29:191\u2013244","DOI":"10.1016\/S0074-7742(08)60087-2"},{"key":"R5P90403524","doi-asserted-by":"crossref","unstructured":"Walkley SU, March PA: Biology of neuronal dysfunction in storage disorders. J Inherit Metab Dis 1993; 16:284\u2013287","DOI":"10.1007\/BF00710266"},{"key":"R5P90403525","doi-asserted-by":"crossref","unstructured":"Siegel DA, Walkley SU: Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside. J Neurochem 1994; 62:1852\u20131862","DOI":"10.1046\/j.1471-4159.1994.62051852.x"},{"key":"R5P90403526","doi-asserted-by":"crossref","unstructured":"Hannun YA, Bell RA: Lysosphingolipids inhibit protein kinase C: implications for the sphinolipidoses. Science 1987; 235:670\u2013673","DOI":"10.1126\/science.3101176"},{"key":"R5P90403527","doi-asserted-by":"crossref","unstructured":"O'Neill B, Butler AB, Young E, et al: Adult onset GM2 gangliosidosis: seizures, dementia and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation. Neurology 1978; 28:1117\u20131123","DOI":"10.1212\/WNL.28.11.1117"},{"key":"R5P90403528","doi-asserted-by":"crossref","unstructured":"Oonk JGW, van der Helm HJ, Martin JJ: Spinocerebellar degeneration: hexosaminidase A and B deficiency in two adult sisters. Neurology 1979; 29:380\u2013384","DOI":"10.1212\/WNL.29.3.380"},{"key":"R5P90403529","unstructured":"Yaffe MG, Kaback M, Goldberg M, et al: An amyotrophic lateral sclerosis-like syndrome with hexosaminidase-A deficiency: a new type of GM2 gangliosidosis (abstract). Neurology 1979; 29:611"},{"key":"R5P90403530","doi-asserted-by":"crossref","unstructured":"Navon R, Argov Z, Brand N, et al: Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype. Neurology 1981; 31:1397\u20131401","DOI":"10.1212\/WNL.31.11.1397"},{"key":"R5P90403531","doi-asserted-by":"crossref","unstructured":"Willner JP, Grabowski GA, Gordon RE, et al: Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic and biochemical studies of nine cases. Neurology 1981; 31:787\u2013798","DOI":"10.1212\/WNL.31.7.787"},{"key":"R5P90403532","doi-asserted-by":"crossref","unstructured":"Johnson WG, Wigger HJ, Karp HR, et al: Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype. Ann Neurol 1982; 11:11\u201316","DOI":"10.1002\/ana.410110103"},{"key":"R5P90403534","unstructured":"Dale AJD, Engel AG, Rudd NL: Familial hexosaminidase A deficiency with Kugelberg-Wellander phenotype and mental change (abstract). Ann Neurol 1983; 14:109"},{"key":"R5P90403535","doi-asserted-by":"crossref","unstructured":"Barbeau A, Plasse L, Cloutier T, et al: Lysosmal enzymes in ataxia: discovery of two new cases of late onset hexosaminidase A and B deficiency (adult Sandhoff disease) in French Canadians. Can J Neurol Sci 1984; 11:601\u2013606","DOI":"10.1017\/S0317167100035125"},{"key":"R5P90403536","doi-asserted-by":"crossref","unstructured":"Mitsumoto H, Sliman R, Schafer IA, et al: Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol 1985; 17:378\u2013385","DOI":"10.1002\/ana.410170413"},{"key":"R5P90403537","doi-asserted-by":"crossref","unstructured":"Parnes S, Karpati G, Carpenter S, et al: Hexosaminidase-A deficiency presenting as atypical juvenile-onset spinal muscular atrophy. Arch Neurol 1985; 42:1176\u20131180","DOI":"10.1001\/archneur.1985.04060110058016"},{"key":"R5P90403538","doi-asserted-by":"crossref","unstructured":"Navon R, Argov Z, Frisch A: Hexosaminidase deficiency in adults. Am J Med Genet 1986; 24:179\u2013196","DOI":"10.1002\/ajmg.1320240123"},{"key":"R5P90403539","doi-asserted-by":"crossref","unstructured":"Oates CE, Bosch EP, Hart MN: Movement disorders associated with chronic GM2 gangliosidosis: case report and review of the literature. Eur Neurol 1986; 25:154\u2013159","DOI":"10.1159\/000116100"},{"key":"R5P90403540","doi-asserted-by":"crossref","unstructured":"Harding E, Young EP, Schon F: Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase deficiency syndrome. J Neurol Neurosurg Psychiatry 1987; 50:687\u2013690","DOI":"10.1136\/jnnp.50.6.687"},{"key":"R5P90403541","doi-asserted-by":"crossref","unstructured":"Lichtenberg P, Navon R, Wertman E, et al: Post-partum psychosis in adult GM2 gangliosidosis: a case report. Br J Psychiatry 1988; 153:387\u2013389","DOI":"10.1192\/bjp.153.3.387"},{"key":"R5P90403542","doi-asserted-by":"crossref","unstructured":"Karni A, Navon R, Sadeh M: Hexosaminidase A deficiency manifesting as spinal muscular atrophy of late onset. Ann Neurol 1988; 24:451\u2013453","DOI":"10.1002\/ana.410240316"},{"key":"R5P90403543","doi-asserted-by":"crossref","unstructured":"Rubin M, Karpati G, Wolfe LS, et al: Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency. J Neurol Sci 1988; 87:103\u2013119","DOI":"10.1016\/0022-510X(88)90058-5"},{"key":"R5P90403544","doi-asserted-by":"crossref","unstructured":"Thomas PK, Young E, King RHM: Sandhoff disease mimicking adult-onset bulbospinal neuronopathy. J Neurol Neurosurg Psychiatry 1989; 52:1103\u20131106","DOI":"10.1136\/jnnp.52.9.1103"},{"key":"R5P90403545","doi-asserted-by":"crossref","unstructured":"Streifler J, Golomb M, Gadoth N: Psychiatric features of adult GM2 gangliosidosis. Br J Psychiatry 1989; 155:410\u2013413","DOI":"10.1192\/bjp.155.3.410"},{"key":"R5P90403546","doi-asserted-by":"crossref","unstructured":"Specola N, Vanier MT, Goutieres F, et al: The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology 1990; 40:145\u2013150","DOI":"10.1212\/WNL.40.1.145"},{"key":"R5P90403547","doi-asserted-by":"crossref","unstructured":"Renshaw PF, Stern TA, Welch C, et al: Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. Ann Neurol 1992; 31:342\u2013344","DOI":"10.1002\/ana.410310320"},{"key":"R5P90403548","doi-asserted-by":"crossref","unstructured":"Hurowitz GI, Silver JM, Brin MF, et al: Neuropsychiatric aspects of adult onset Tay-Sachs disease: two case reports with several new findings. J Neuropsychiatry Clin Neurosci 1993; 5:30\u201336","DOI":"10.1176\/jnp.5.1.30"},{"key":"R5P90403549","unstructured":"Rosebush PI, MacQueen G, Mazurek MF: Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry 1995; 56:347\u2013353"},{"key":"R5P90403550","doi-asserted-by":"crossref","unstructured":"Federico A, Palmeri S, Malandrini A, et al: The clinical aspects of adult hexosaminidase deficiencies. Dev Neurosci 1991; 13:280\u2013287","DOI":"10.1159\/000112174"},{"key":"R5P90403552","doi-asserted-by":"crossref","unstructured":"Coker SB: The diagnosis of childhood degenerative disorders presenting as dementia in adults. Neurology 1991; 41:794\u2013798","DOI":"10.1212\/WNL.41.6.794"},{"key":"R5P90403554","doi-asserted-by":"crossref","unstructured":"Grigsby JP, Kemper, MB, Hagerman RJ, et al: Neuropsychological dysfunction among affected heterozygous fragile X females. Am J Med Genet 1990; 35:28\u201335","DOI":"10.1002\/ajmg.1320350107"},{"key":"R5P90403555","doi-asserted-by":"crossref","unstructured":"Reiss AL, Hagerman RJ, Vinogradov S, et al: Psychiatric disability in female carriers of the fragile X chromosome. Arch Gen Psychiatry 1988; 45:25\u201330","DOI":"10.1001\/archpsyc.1988.01800250029005"},{"key":"R5P90403556","doi-asserted-by":"crossref","unstructured":"Moser HW, Moser AE, Singh I, et al: Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol 1984; 16:628\u2013664","DOI":"10.1002\/ana.410160603"},{"key":"R5P90403557","doi-asserted-by":"crossref","unstructured":"Manowitz P, Kling A, Kohn H: Clinical course of adult metachromatic leukodystrophy presenting as schizophrenia: a report of two living cases in siblings. J Nerv Ment Dis 1978; 166:500\u2013506","DOI":"10.1097\/00005053-197807000-00005"},{"key":"R5P90403558","doi-asserted-by":"crossref","unstructured":"Betts TA, Smith WT, Kelly RE: Adult metachromatic leukodystrophy (sulphatide lipidosis) simulating acute schizophrenia: report of a case. Neurology 1968; 18:1140\u20131142","DOI":"10.1212\/wnl.18.11.1140"},{"key":"R5P90403559","doi-asserted-by":"crossref","unstructured":"Finelli P: Metachromatic leukodystrophy manifesting as a schizophrenic disorder: computed tomographic correlation. Ann Neurol 1985; 18:94\u201395","DOI":"10.1002\/ana.410180117"},{"key":"R5P90403560","doi-asserted-by":"crossref","unstructured":"Mahon-Haft H, Stone RK, Johnson R, et al: Biochemical abnormalities of metachromatic leukodystrophy in an adult psychiatric population. Am J Psychiatry 1981; 138:1372\u20131374","DOI":"10.1176\/ajp.138.10.1372"},{"key":"R5P90403561","doi-asserted-by":"crossref","unstructured":"Austin J, Armstrong D, Fouch S, et al: Metachromatic leukodystrophy (MLD), VIII: MLD in adults\u2014diagnosis and pathogenesis. Arch Neurol 1968; 18:225\u2013239","DOI":"10.1001\/archneur.1968.00470330015001"},{"key":"R5P90403562","doi-asserted-by":"crossref","unstructured":"Wulff CH, Trojaborg W: Adult metachromatic leukodystrophy: neurophysiologic findings. Neurology 1985; 35:1776\u20131778","DOI":"10.1212\/WNL.35.12.1776"},{"key":"R5P90403563","doi-asserted-by":"crossref","unstructured":"Waldman AJ: Sometimes when you hear hoofbeats\u2026two cases of inherited metabolic diseases with initial presentation of psychiatric symptoms (letter). J Neuropsychiatry Clin Neurosci 1992; 4:113\u2013114","DOI":"10.1176\/jnp.4.1.113"},{"key":"R5P90403564","doi-asserted-by":"crossref","unstructured":"Berkovic SF, Carpenter S, Andermann F, et al: Kufs' disease: a critical reappraisal. Brain 1988; 111:27\u201362","DOI":"10.1093\/brain\/111.1.27"},{"key":"R5P90403566","unstructured":"Sandyk R: Adult neuronal ceroid lipofuscinosis (Kufs' disease): a sporadic case. S Afr Med J 1981; 7:754\u2013755"},{"key":"R5P90403567","doi-asserted-by":"crossref","unstructured":"Starosta-Rubenstein S, Young AB, Kluin K, et al: Clinical assessment of thirty-one patients with Wilson's disease: correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987; 44:365\u2013370","DOI":"10.1001\/archneur.1987.00520160007005"},{"key":"R5P90403568","doi-asserted-by":"crossref","unstructured":"Dening TR, Berrios GE: Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46:1126\u20131134","DOI":"10.1001\/archpsyc.1989.01810120068011"},{"key":"R5P90403570","doi-asserted-by":"crossref","unstructured":"Vanier MT, Rodriguez-Lafrasse C, Rousson R, et al: Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci 1991; 13:307\u2013314","DOI":"10.1159\/000112178"},{"key":"R5P90403571","doi-asserted-by":"crossref","unstructured":"Fink JK, Filling-Katz MR, Sokol J: Clinical spectrum of Niemann-Pick disease type C. Neurology 1989; 39:1040\u20131049","DOI":"10.1212\/WNL.39.8.1040"},{"key":"R5P90403572","doi-asserted-by":"crossref","unstructured":"Berginer VM, Foster NL, Sadowsky M, et al: Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Am J Psychiatry 1988; 145:354\u2013357","DOI":"10.1176\/ajp.145.3.354"},{"key":"R5P90403573","doi-asserted-by":"crossref","unstructured":"Dotti MT, Salen G, Federico A: Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing. Dev Neurosci 1991; 13:371\u2013376","DOI":"10.1159\/000112187"},{"key":"R5P90403574","doi-asserted-by":"crossref","unstructured":"Streifler JY, Gornish M, Hadar H, et al: Brain imaging in late-onset GM2 gangliosidosis. Neurology 1993; 43:2055\u20132058","DOI":"10.1212\/WNL.43.10.2055"},{"key":"R5P90403575","doi-asserted-by":"crossref","unstructured":"Lullman H, Lullman-Rauch R, Wassermann D: Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 1978; 27:1103\u20131108","DOI":"10.1016\/0006-2952(78)90435-5"},{"key":"R5P90403576","doi-asserted-by":"crossref","unstructured":"Palmeri S, Mangano L, Battisti C, et al: Imipramine induced lipidosis and dexamethasone effect: morphological and biochemical study in normal and chronic GM2 gangliosidosis fibroblasts. J Neurol Sci 1992; 110:215\u2013221","DOI":"10.1016\/0022-510X(92)90030-O"},{"key":"R5P90403577","unstructured":"Rosebush PI, Hildebrand AM, Furlong BG, et al: Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990; 51:357\u2013362"},{"key":"R5P90403578","unstructured":"Gaind GS, Rosebush PI, Mazurek MF: Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry 1994; 55:20\u201323"}],"container-title":["The Journal of Neuropsychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.10.1.10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T16:33:48Z","timestamp":1722184428000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.10.1.10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1176\/jnp.10.1.10"],"URL":"https:\/\/doi.org\/10.1176\/jnp.10.1.10","relation":{},"ISSN":["0895-0172","1545-7222"],"issn-type":[{"value":"0895-0172","type":"print"},{"value":"1545-7222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}